Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

News

An Emerging Tech Center: Oklahoma City notable home-grown startups

By zach | News | 0 comment | 29 February, 2016 | 0

An Emerging Tech Center: Oklahoma City notable home-grown startups in Innovation Magazine Copyright © 2016 | Innovation America Accele BioPharma (founded in 2011) — Biotechnology business accelerator located in the University Research Park, formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies. http://accelebio.com Analytical Research Laboratories/DNA Solutions/The KupiecRead more

A window shuts and doors open for Carol Curtis

By admin | Entrepreneur, Fellowship News, News, SeedStep Angels, Uncategorized | Comments are Closed | 8 March, 2015 | 0

Just when she lined up potential opportunities with three Florida biotech companies, Carol Curtis’ husband was transferred to Oklahoma City. Call it serendipity.

Grant supports research for sickle cell pill

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 9 December, 2014 | 0

Robert Broyles received $218,000 to advance his business, and he aims to turn it into more than $1 million for Oklahoma City-based EpimedX.

State researcher on quest for sickle cell cure

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 17 August, 2014 | 0

Robert Broyles, in his work at the OU Health Science Center and National Institutes of Health, discovered that a molecule called ferritin-H would likely cause the switch back to fetal hemoglobin.

Oklahoma Innovations for Sept. 14-15

By admin | Entrepreneur, News, OCAST news, Publish in TEN | Comments are Closed | 12 September, 2013 | 0

On this week’s Oklahoma Innovations radio show, learn how researchers at EpimedX have disdovered a safe plant growth factor with the potential to effectively prevent the manifestations of sickle cell disease.

EpimedX featured in OK Magazine

By admin | Blog, Entrepreneurs, Investment, SeedStep Angels | Comments are Closed | 15 May, 2013 | 0

i2E client EpmedX and its co-founder, Dr. Robert Broyles, were recently featured in the April edition of Oklahoma Magazine.

EpimedX gets i2E concept funds

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 5 February, 2013 | 0

The nonprofit i2E Inc. has approved Oklahoma City-based EpimedX LLC for $200,000 in matching financing through its Concept Fund program.

EpimedX OK’d for funding from i2E

By admin | Entrepreneur, Investment, News, SeedStep Angels | Comments are Closed | 4 February, 2013 | 0

Oklahoma City-based EpimedX, LLC., has been approved for a matching financing round of $200,000 from i2E, Inc., through the Concept Fund.

Biotech startup seeks funding for trials

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 10 January, 2013 | 0

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the U.S.

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E